QrumPharma Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
QrumPharma General Information
Description
Operator of a pharmaceutical company developing inhalation treatments for severe chronic and recurrent pulmonary infections. The company is developing a drug for the treatment of Nontuberculous Mycobacteria (NTM) and Tuberculosis.
Contact Information
Website
www.qrumpharma.comCorporate Office
- 215 Decatur Street
- Doylestown, PA 18901
- United States
Corporate Office
- 215 Decatur Street
- Doylestown, PA 18901
- United States
QrumPharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
QrumPharma Comparisons
Industry
Financing
Details
QrumPharma Competitors (36)
One of QrumPharma’s 36 competitors is Verona Pharma, a Corporate Backed or Acquired company based in London, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Verona Pharma | Corporate Backed or Acquired | London, United Kingdom | ||||
| Eloxx Pharmaceuticals | Formerly VC-backed | Arlington, MA | ||||
| Avalyn Pharma | Formerly VC-backed | Boston, MA | ||||
| Enterprise Therapeutics | Venture Capital-Backed | Brighton, United Kingdom | ||||
| Sarepta Therapeutics | Formerly VC-backed | Cambridge, MA |
QrumPharma Patents
QrumPharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2020123336-A1 | Compositions of bedaquiline, combinations comprising them, processes for their preparation, uses and methods of treatment comprising them | Inactive | 13-Dec-2018 | ||
| WO-2020040818-A1 | Compositions of clofazimine, combinations comprising them, processes for their preparation, uses and methods comprising them | Inactive | 23-Aug-2018 | ||
| WO-2019110099-A1 | Inhalable clofazimine formulation | Inactive | 06-Dec-2017 | A61P31/06 |
QrumPharma FAQs
-
Where is QrumPharma headquartered?
QrumPharma is headquartered in Doylestown, PA.
-
What industry is QrumPharma in?
QrumPharma’s primary industry is Drug Discovery.
-
Is QrumPharma a private or public company?
QrumPharma is a Private company.
-
What is the current valuation of QrumPharma?
The current valuation of QrumPharma is .
-
What is QrumPharma’s current revenue?
The current revenue for QrumPharma is .
-
Who are QrumPharma’s competitors?
Verona Pharma, Eloxx Pharmaceuticals, Avalyn Pharma, Enterprise Therapeutics, and Sarepta Therapeutics are some of the 36 competitors of QrumPharma.
-
When was QrumPharma acquired?
QrumPharma was acquired on 07-Dec-2020.
-
Who acquired QrumPharma?
QrumPharma was acquired by MannKind.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process